These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 33864233)

  • 61. Collagen scaffold enhances the regenerative properties of mesenchymal stromal cells.
    Rashedi I; Talele N; Wang XH; Hinz B; Radisic M; Keating A
    PLoS One; 2017; 12(10):e0187348. PubMed ID: 29088264
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Rapamycin-Preactivated Autophagy Enhances Survival and Differentiation of Mesenchymal Stem Cells After Transplantation into Infarcted Myocardium.
    Li ZH; Wang YL; Wang HJ; Wu JH; Tan YZ
    Stem Cell Rev Rep; 2020 Apr; 16(2):344-356. PubMed ID: 31927699
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cardiac Adipose-Derived Stem Cells Exhibit High Differentiation Potential to Cardiovascular Cells in C57BL/6 Mice.
    Nagata H; Ii M; Kohbayashi E; Hoshiga M; Hanafusa T; Asahi M
    Stem Cells Transl Med; 2016 Feb; 5(2):141-51. PubMed ID: 26683873
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Repair of senescent myocardium by mesenchymal stem cells is dependent on the age of donor mice.
    Khan M; Mohsin S; Khan SN; Riazuddin S
    J Cell Mol Med; 2011 Jul; 15(7):1515-27. PubMed ID: 20041970
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Characterization of rat very small embryonic-like stem cells and cardiac repair after cell transplantation for myocardial infarction.
    Wu JH; Wang HJ; Tan YZ; Li ZH
    Stem Cells Dev; 2012 May; 21(8):1367-79. PubMed ID: 22032240
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Macrophage migration inhibitory factor rejuvenates aged human mesenchymal stem cells and improves myocardial repair.
    Zhang Y; Zhu W; He H; Fan B; Deng R; Hong Y; Liang X; Zhao H; Li X; Zhang F
    Aging (Albany NY); 2019 Dec; 11(24):12641-12660. PubMed ID: 31881006
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction.
    Williams AR; Hatzistergos KE; Addicott B; McCall F; Carvalho D; Suncion V; Morales AR; Da Silva J; Sussman MA; Heldman AW; Hare JM
    Circulation; 2013 Jan; 127(2):213-23. PubMed ID: 23224061
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cardiac repair in a mouse model of acute myocardial infarction with trophoblast stem cells.
    Li G; Chen J; Zhang X; He G; Tan W; Wu H; Li R; Chen Y; Gu R; Xie J; Xu B
    Sci Rep; 2017 Mar; 7():44376. PubMed ID: 28295048
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immunomodulation by systemic administration of human-induced pluripotent stem cell-derived mesenchymal stromal cells to enhance the therapeutic efficacy of cell-based therapy for treatment of myocardial infarction.
    Sun SJ; Lai WH; Jiang Y; Zhen Z; Wei R; Lian Q; Liao SY; Tse HF
    Theranostics; 2021; 11(4):1641-1654. PubMed ID: 33408772
    [No Abstract]   [Full Text] [Related]  

  • 70. In situ activated mesenchymal stem cells (MSCs) by bioactive hydrogels for myocardial infarction treatment.
    Gao L; Yi M; Xing M; Li H; Zhou Y; Xu Q; Zhang Z; Wen Z; Chang J
    J Mater Chem B; 2020 Sep; 8(34):7713-7722. PubMed ID: 32724972
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Blocking exosomal miRNA-153-3p derived from bone marrow mesenchymal stem cells ameliorates hypoxia-induced myocardial and microvascular damage by targeting the ANGPT1-mediated VEGF/PI3k/Akt/eNOS pathway.
    Ning W; Li S; Yang W; Yang B; Xin C; Ping X; Huang C; Gu Y; Guo L
    Cell Signal; 2021 Jan; 77():109812. PubMed ID: 33164880
    [TBL] [Abstract][Full Text] [Related]  

  • 72. In Situ Preconditioning of Human Mesenchymal Stem Cells Elicits Comprehensive Cardiac Repair Following Myocardial Infarction.
    Sim WS; Park BW; Ban K; Park HJ
    Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33535594
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Can the outcomes of mesenchymal stem cell-based therapy for myocardial infarction be improved? Providing weapons and armour to cells.
    Karpov AA; Udalova DV; Pliss MG; Galagudza MM
    Cell Prolif; 2017 Apr; 50(2):. PubMed ID: 27878916
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis.
    Nagaya N; Fujii T; Iwase T; Ohgushi H; Itoh T; Uematsu M; Yamagishi M; Mori H; Kangawa K; Kitamura S
    Am J Physiol Heart Circ Physiol; 2004 Dec; 287(6):H2670-6. PubMed ID: 15284059
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pretreatment of human mesenchymal stem cells with pioglitazone improved efficiency of cardiomyogenic transdifferentiation and cardiac function.
    Shinmura D; Togashi I; Miyoshi S; Nishiyama N; Hida N; Tsuji H; Tsuruta H; Segawa K; Tsukada Y; Ogawa S; Umezawa A
    Stem Cells; 2011 Feb; 29(2):357-66. PubMed ID: 21732492
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A role for Gcn5 in cardiomyocyte differentiation of rat mesenchymal stem cells.
    Li L; Zhu J; Tian J; Liu X; Feng C
    Mol Cell Biochem; 2010 Dec; 345(1-2):309-16. PubMed ID: 20835911
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Enhanced Cardioprotection by Human Endometrium Mesenchymal Stem Cells Driven by Exosomal MicroRNA-21.
    Wang K; Jiang Z; Webster KA; Chen J; Hu H; Zhou Y; Zhao J; Wang L; Wang Y; Zhong Z; Ni C; Li Q; Xiang C; Zhang L; Wu R; Zhu W; Yu H; Hu X; Wang J
    Stem Cells Transl Med; 2017 Jan; 6(1):209-222. PubMed ID: 28170197
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Embryonic cardiomyocyte, but not autologous stem cell transplantation, restricts infarct expansion, enhances ventricular function, and improves long-term survival.
    Paulis LE; Klein AM; Ghanem A; Geelen T; Coolen BF; Breitbach M; Zimmermann K; Nicolay K; Fleischmann BK; Roell W; Strijkers GJ
    PLoS One; 2013; 8(4):e61510. PubMed ID: 23585908
    [TBL] [Abstract][Full Text] [Related]  

  • 79. MicroRNAs as a Novel Player for Differentiation of Mesenchymal Stem Cells into Cardiomyocytes.
    Azizidoost S; Farzaneh M
    Curr Stem Cell Res Ther; 2023; 18(1):27-34. PubMed ID: 35466882
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mechanisms of stem cell based cardiac repair-gap junctional signaling promotes the cardiac lineage specification of mesenchymal stem cells.
    Lemcke H; Gaebel R; Skorska A; Voronina N; Lux CA; Petters J; Sasse S; Zarniko N; Steinhoff G; David R
    Sci Rep; 2017 Aug; 7(1):9755. PubMed ID: 28852100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.